Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (4) 4
humans (4) 4
male (4) 4
adult (3) 3
middle aged (3) 3
adolescent (2) 2
aged (2) 2
allergy and immunology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
child (2) 2
desensitization, immunologic - methods (2) 2
graft rejection - epidemiology (2) 2
hla antigens - immunology (2) 2
immune globulin (2) 2
immunoglobulins, intravenous - adverse effects (2) 2
immunoglobulins, intravenous - therapeutic use (2) 2
immunologic factors - adverse effects (2) 2
immunology (2) 2
index medicus (2) 2
kidney transplantation (2) 2
kidney-transplantation (2) 2
living-donor (2) 2
recipients (2) 2
rheumatoid-arthritis (2) 2
rituximab (2) 2
safety (2) 2
t-cells (2) 2
transplantation (2) 2
abridged index medicus (1) 1
acute kidney injury - chemically induced (1) 1
acute kidney injury - epidemiology (1) 1
acute-renal-failure (1) 1
aged, 80 and over (1) 1
alemtuzumab (1) 1
allograft-rejection (1) 1
anti-hla antibodies (1) 1
antibodies (1) 1
antibodies - blood (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, murine-derived (1) 1
antibodies, monoclonal, murine-derived - immunology (1) 1
antibodies, monoclonal, murine-derived - therapeutic use (1) 1
antibodies, neoplasm - immunology (1) 1
antibodies, neoplasm - therapeutic use (1) 1
antibody mediated rejection (1) 1
antigens, cd19 - blood (1) 1
antigens, cd20 - immunology (1) 1
b-cell depletion (1) 1
b-cells (1) 1
b-lymphocytes - metabolism (1) 1
cd3 complex - biosynthesis (1) 1
cell (1) 1
cell count (1) 1
child, preschool (1) 1
control (1) 1
creatinine - blood (1) 1
cross-match (1) 1
cytomegalovirus infections - drug therapy (1) 1
cytomegalovirus infections - immunology (1) 1
desensitization (1) 1
desensitization, immunologic - adverse effects (1) 1
disease (1) 1
donor kidney-transplantation (1) 1
double-blind (1) 1
drug therapy, combination (1) 1
efficacy (1) 1
elderly-patients (1) 1
evaluation (1) 1
flow cytometry (1) 1
flow cytometry - methods (1) 1
flow-cytometry (1) 1
graft rejection - diagnosis (1) 1
graft rejection - immunology (1) 1
graft rejection - prevention & control (1) 1
hla antibodies (1) 1
immunization (1) 1
immunoglobulin g - immunology (1) 1
immunoglobulin g - therapeutic use (1) 1
immunoglobulin therapy (1) 1
immunoglobulins (1) 1
immunoglobulins - blood (1) 1
immunoglobulins, intravenous - immunology (1) 1
immunologic factors - therapeutic use (1) 1
immunologic memory (1) 1
immunosuppression - methods (1) 1
induction therapy (1) 1
infant (1) 1
interferon gamma (1) 1
interferon-gamma - immunology (1) 1
interferon-gamma - metabolism (1) 1
intravenous immune globulin (1) 1
intravenous immunoglobulin (1) 1
kidney transplantation - immunology (1) 1
medicine, general & internal (1) 1
monitoring (1) 1
monitoring, immunologic (1) 1
myocardial infarction - chemically induced (1) 1
myocardial infarction - epidemiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
by Vo, Ashley A and Lukovsky, Marina and Toyoda, Mieko and Wang, Jennifer and Reinsmoen, Nancy L and Lai, Chih-Hung and Peng, Alice and Villicana, Rafael and Jordan, Stanley C
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 3, pp. 242 - 251
This open-label, phase 1–2, single-center study examined the use of intravenous immune globulin and rituximab to reduce anti-HLA antibodies and improve... 
RHEUMATOID-ARTHRITIS | MEDICINE, GENERAL & INTERNAL | CROSS-MATCH | THERAPY | SENSITIZED PATIENTS | KIDNEY-TRANSPLANTATION | LIVING-DONOR | ANTI-HLA ANTIBODIES | DISEASE | RECIPIENTS | CELL | Antigens, CD20 - immunology | Antibodies, Monoclonal, Murine-Derived | Immunosuppression - methods | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Immunoglobulins, Intravenous - adverse effects | HLA Antigens - immunology | Rituximab | Antibodies, Monoclonal - therapeutic use | Male | Survival Rate | Graft Rejection - epidemiology | Immunoglobulins, Intravenous - therapeutic use | Creatinine - blood | Adult | Antibodies - blood | Female | Antigens, CD19 - blood | Immunologic Factors - adverse effects | Drug Therapy, Combination | Kidney Transplantation - immunology | Desensitization, Immunologic - methods | Immunologic Factors - therapeutic use | Viral antibodies | Evaluation | Control | Usage | Immunoglobulins | Antibodies | Drug therapy, Combination | Studies | Transplants & implants | Pharmaceutical industry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience
by Vo, Ashley A and Cam, Vinh and Toyoda, Mieko and Puliyanda, Dechu P and Lukovsky, Marina and Bunnapradist, Suphamai and Peng, Alice and Yang, Kai and Jordan, Stanley C
Clinical journal of the American Society of Nephrology : CJASN, ISSN 1555-905X, 2006, Volume 1, Issue 4, pp. 844 - 852
Intravenous Ig (IVIg) products are used in various medical conditions. Differences in excipients account for most adverse events (AE). Reports of complications... 
RAPID INFUSION | MYOCARDIAL-INFARCTION | KIDNEY-TRANSPLANTATION | LIVING-DONOR | IMMUNE GLOBULIN | UROLOGY & NEPHROLOGY | THROMBOEMBOLIC EVENTS | ACUTE-RENAL-FAILURE | IMMUNOGLOBULIN THERAPY | SERUM VISCOSITY | ELDERLY-PATIENTS | Myocardial Infarction - chemically induced | Myocardial Infarction - epidemiology | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Infant | Male | Adolescent | Aged, 80 and over | Adult | Female | Acute Kidney Injury - chemically induced | Aged | Immunologic Factors - adverse effects | Retrospective Studies | Acute Kidney Injury - epidemiology | Safety | Child
Journal Article
Details down arrow
3. Full Text Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab
by Ge, Shili and Pao, Andy and Vo, Ashley and Deer, Nathan and Karasyov, Artur and Petrosyan, Anna and Kahwaji, Joseph and Lukovsky, Marina and Chai, Ning-Ning and Aguiluz, Angela and Mirocha, James and Jordan, Stanley C and Toyoda, Mieko
Transplant Immunology, ISSN 0966-3274, 2010, Volume 24, Issue 3, pp. 142 - 148
Abstract Desensitization with IVIG and rituximab followed by transplantation with alemtuzumab or daclizumab induction is an effective clinical protocol. Here,... 
Allergy and Immunology | Rituximab | Intravenous immunoglobulin (IVIG) | Desensitization | Safety | Alemtuzumab | Kidney transplantation | RHEUMATOID-ARTHRITIS | EFFICACY | B-CELL DEPLETION | IMMUNE GLOBULIN | IMMUNOLOGY | RENAL-TRANSPLANT RECIPIENTS | TRANSPLANTATION | INDUCTION THERAPY | REJECTION | DOUBLE-BLIND | T-CELLS | Antibodies, Neoplasm - therapeutic use | Humans | Monitoring, Immunologic | Antibodies, Monoclonal - therapeutic use | Male | Cytomegalovirus Infections - immunology | Antibodies, Monoclonal, Humanized | Desensitization, Immunologic - adverse effects | T-Lymphocytes - metabolism | Immunoglobulin G - immunology | Immunoglobulins - blood | Female | Antibodies, Monoclonal - immunology | B-Lymphocytes - metabolism | Antibodies, Neoplasm - immunology | Antibodies, Monoclonal, Murine-Derived - immunology | Graft Rejection - prevention & control | Immunoglobulin G - therapeutic use | Kidney Transplantation | Immunoglobulins, Intravenous - therapeutic use | Cytomegalovirus Infections - drug therapy | Immunoglobulins, Intravenous - immunology | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Desensitization, Immunologic - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Intracellular IFNγ production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization
by Toyoda, Mieko and Pao, Andy and Vo, Ashley and Lukovsky, Marina and Radha, Raju and Sado, Tetsu and Ge, Shili and Reinsmoen, Nancy and Chai, Ning Ning and Baden, Lara and Petrosyan, Anna and Skinner, Edwina and Mirocha, James and Jordan, Stanley C
Transplant Immunology, ISSN 0966-3274, 2009, Volume 22, Issue 3, pp. 121 - 127
Abstract Background Sensitization to HLA antigens (Ags) is a significant obstacle to kidney transplantation and risk factor for antibody-mediated rejection... 
Allergy and Immunology | Antibody mediated rejection | Flow cytometry | Sensitization | Monitoring | Interferon gamma | ALLOGRAFT-REJECTION | NATURAL-KILLER-CELLS | RENAL-TRANSPLANTATION | DONOR KIDNEY-TRANSPLANTATION | IMMUNOLOGY | RECIPIENTS | TRANSPLANTATION | B-CELLS | INTRAVENOUS IMMUNE GLOBULIN | FLOW-CYTOMETRY | T-CELLS | HLA ANTIBODIES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Intracellular IFNg production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization
by Toyoda, Mieko and Pao, Andy and Vo, Ashley and Lukovsky, Marina and Radha, Raju and Sado, Tetsu and Ge, Shili and Reinsmoen, Nancy and Chai, Ning Ning and Baden, Lara and Petrosyan, Anna and Skinner, Edwina and Mirocha, James and Jordan, Stanley C
Transplant Immunology, ISSN 0966-3274, 02/2010, Volume 22, Issue 3-4, pp. 121 - 127
Sensitization to HLA antigens (Ags) is a significant obstacle to kidney transplantation and risk factor for antibody-mediated rejection (AMR). Current... 
Journal Article
Details down arrow
6. Full Text Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization
by Toyoda, Mieko and Pao, Andy and Vo, Ashley and Lukovsky, Marina and Radha, Raju and Sado, Tetsu and Ge, Shili and Reinsmoen, Nancy and Chai, Ning Ning and Baden, Lara and Petrosyan, Anna and Skinner, Edwina and Mirocha, James and Jordan, Stanley C
Transplant immunology, 02/2010, Volume 22, Issue 3-4, p. 121
Sensitization to HLA antigens (Ags) is a significant obstacle to kidney transplantation and risk factor for antibody-mediated rejection (AMR). Current... 
Flow Cytometry - methods | Immunization | Cell Count | Humans | Middle Aged | Risk Factors | HLA Antigens - immunology | Male | Kidney Transplantation | Graft Rejection - diagnosis | Interferon-gamma - metabolism | CD3 Complex - biosynthesis | Pregnancy | Graft Rejection - epidemiology | Interferon-gamma - immunology | Adolescent | Sex Factors | Adult | Female | Immunologic Memory | Aged | Graft Rejection - immunology | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.